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Abstract
Background: Retinal inflammation is a devastating pathological process in ocular diseases. Functional impairment
of retinal pigment epithelium (RPE) is associated with inflammatory retinal diseases. Enhancing the protective axis
namely ACE2/Ang-(1-7)/Mas by activation of ACE2 presents anti-inflammatory properties. We investigated whether
diminazene aceturate (DIZE), an angiotensin-converting enzyme 2 (ACE2) activator, prevented lipopolysaccharide
(LPS)-induced inflammatory response by activating the protective axis and whether the effect was mediated by
inhibiting the mitogen-activated protein kinase (MAPK) and the nuclear factor-κB (NF-κB) pathways.
Methods: Cell counting kit-8 (CCK-8) assay and real-time PCR were used to determine the optimum concentration
and incubation time of DIZE. ARPE-19 cells and primary cultured human retinal pigment epithelia (hRPE) were
incubated with or without 10 μg/mL DIZE for 6 h before stimulated with 5 μg/mL LPS for 24 h. The mRNA
expression of inflammatory cytokines, AT1R, and AT2R was analyzed. The protein level of inflammatory cytokines,
Ang II, and Ang-(1-7) was detected. Phosphorylation of p38 MAPK, extracellular signal-regulated kinase (ERK)1/2,
c-Jun N-terminal kinase (JNK) and phosphorylated transcription inhibition factor-κB-α (p-IκB-α) were measured.
Inhibitors of MAPKs and NF-κB were added to verify the involvement of these pathways. A small interfering RNA
(siRNA) targeted to ACE2 and a selective Ang-(1-7) antagonist A779 was used to confirm the role of ACE2 and the
involvement of ACE2/Ang-(1-7)/Mas axis.
Results: DIZE remarkably increased the expression of ACE2 and inhibited the expression of IL-6, IL-8, and MCP-1 at
both mRNA and protein levels in both RPE cell lines stimulated with LPS. Inhibitors of p38, ERK1/2, JNK, and NF-κB
significantly decreased LPS-induced overproduction of IL-6, IL-8, and MCP-1. DIZE reduced the expression of Ang II
and AT1R, whereas increased Ang-(1-7). Furthermore, DIZE downregulated the phosphorylation of p38MAPK, ERK1/
2, JNK, and the activation of NF-κB upon stimulation with LPS. Downregulating ACE2 and pre-treatment with A779
abrogated the effects of DIZE on production of cytokines, the expression of Ang II, Ang-(1-7), AT1R, phosphorylation
of MAPKs and activation of NF-κB.
Conclusions: DIZE inhibits LPS-induced inflammatory response by activating ACE2/Ang-(1-7)/Mas axis in human
RPE cells. The protective effect is mediated by inhibiting the p38MAPK, ERK1/2, JNK, and NF-κB pathways.
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Background
The renin-angiotensin system (RAS) is a complex hor-
mone system and classically known as a regulator of
blood pressure. It is also recognized recently as a pro-
inflammatory mediator [1]. In addition to systemic RAS,
tissue intrinsic RAS has been identified in various tissues
including the retina. The malfunction of tissue intrinsic
RAS is involved in the pathogenesis of vascular [2],
pulmonary [3] and ocular diseases [4]. Angiotensin II
(Ang II) is a vital molecular regulator of RAS. It is
generated through sequential enzymatic catalysis by
angiotensin-converting enzyme (ACE) from angioten-
sinogen. Ang II has two receptors, angiotensin II type
1 receptor (AT1R) and AT2R. It has been proved that
Ang II plays the deleterious roles through its receptor
AT1R. Several studies demonstrated that the harmful
axis of RAS, i.e., the ACE/Ang II/AT1R axis was in-
volved in several retinal diseases [4, 5]. Therapeutic
intervention targeted to this axis showed remarkable
protective effects. AT1R blocker (ARB) suppressed
retinal neural dysfunction and downregulated the
expression of pro-inflammatory cytokines in animal
models of acute retinal inflammation [6]. In addition,
oral administration of ARB prevented the progression
of diabetic retinopathy by attenuating infiltration of
leukocytes in the retina and delays the development
of diabetic retinopathy [7].
Angiotensin-converting enzyme 2 (ACE2), a newly
found component of RAS, is an enzymatic homologue of
ACE. ACE2 decreases the generation of Ang II by cata-
lyzing the conversion of Ang II to angiotensin-(1-7)
[Ang-(1-7)], which inhibits the vasoconstrictive, inflam-
matory, and oxidation stress effects of Ang II [8, 9].
Studies show that the ACE2/Ang-(1-7)/Mas axis is the
protective axis of RAS [9]. This axis presents a broad
range of beneficial effects including improving patho-
logical conditions such as inflammation and fibrosis
[10]. In fact, recombinant ACE2 effectively decreases
the cell apoptosis rate and inflammatory cytokines
protein levels on LPS-induced pulmonary microvascu-
lar endothelial cells (PMVECs) by inhibiting c-Jun N-
terminal kinase (JNK) and nuclear factor-κB (NF-κB)
pathways [11]. Existing evidence considers that in-
creased expression of ACE2 and Ang-(1-7) via adeno-
associated virus (AAV)-mediated gene delivery in the
retina diminishes diabetes-induced retinal inflamma-
tion and vascular pathology [12]. These studies
propose an idea that enhancing the ACE2/Ang-(1-7)/
Mas axis may be a promising approach for retinal in-
flammatory diseases.
Recently studies show that diminazene aceturate
(DIZE), a classical drug for trypanosomiasis and
babesiosis, is an activator of ACE2 [13]. It is capable to
increase the enzymatic activity of ACE2, thus activates
the protective axis of RAS: ACE2/Ang-(1-7)/Mas [14]
and exerts anti-inflammatory role in pathological con-
ditions. It has been suggested that DIZE reduces serum
levels of pro-inflammatory cytokines by directly altering
the production of these cytokines in macrophages [15],
and exerts anti-inflammation effects under many
inflammatory pathological processes including myocar-
dia ischemia [13], pulmonary hypertension [16], and
endotoxin-induced uveitis (EIU) [14, 17]. However, how
DIZE exerts its anti-inflammatory effect as an ACE2
activator remains unclear.
As a part of the central nervous system (CNS), the ret-
ina plays an essential role in the formation of vision.
The retinal pigment epithelium (RPE) regulates the
transport of nutrients and waste products from the ret-
ina, and contributes to outer segment renewal by ingest-
ing and degrading the spent debris of photoreceptor
outer segments [18]. Thus, RPE plays crucial roles in
maintaining normal retinal function [19]. Dysfunction of
RPE cells is involved in many inflammatory blind-
causing ocular diseases, including age-related macular
disease (AMD) [20]. Oxidative stress, lipofuscin accumu-
lation in RPE cells are well-known pathological features
of AMD [21]. In addition, inflammation of RPE exacer-
bates AMD because infiltrating macrophages promote
choroidal neovascularization (CNV) [22]. We used pri-
mary cultured human RPE isolated from the donor eyes
and a human RPE-derived cell line ARPE-19, which has
similar structural and functional characteristics of RPE
[23] in this study.
Lipopolysaccharide (LPS) induces acute inflammatory
responses of RPE in many ocular pathological conditions
including bacterial endophthalmitis and uveitis [24, 25].
Interleukin (IL)-6, IL-8, and monocyte chemoattractant
protein-1 (MCP-1) are representative cytokines that
initiate ocular inflammation. Inflammatory response me-
diated by LPS stimulation results in secretion of a series
of cytokines through IL-6 and IL-8 autocrine signaling
in ARPE-19 cells [25]. IL-6 plays a critical role in many
intraocular inflammatory diseases [26, 27]. MCP-1 and
IL-8 are thought to be the major mediator for neutrophil
and monocyte infiltration in retinal inflammatory dis-
eases [28]. It has been revealed that IL-6 and IL-8 play
an important role in inflammation associated with the
development of AMD [29]. Moreover, MCP-1 contrib-
utes to inflammatory disorder and the formation of
CNV [30]. IL-6, IL-8, and MCP-1 levels are significantly
higher in aqueous humor of patients with exudative
AMD [31].
Studies have demonstrated that LPS-activated NF-κB
and mitogen-activated protein kinase (MAPK) cascades
upon recognition by toll-like receptor 4 on the cellular
surface and led to the release of pro-inflammatory
cytokines [32]. In addition, DIZE reduces LPS-induced
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production of inflammatory cytokines by downregulating
phosphorylation of MAPK and activation of NF-κB in
macrophages [33]. We hypothesize that DIZE attenuates
LPS-induced inflammatory response by activating the
ACE2/Ang-(1-7)/Mas axis, and the protective effect is
mediated by inhibiting the MAPK and NF-κB pathways.
Methods
Cell culture
Human primary retinal pigment epithelia (hRPE) were
obtained from donors of the Chongqing Eye Bank. The
hRPE were obtained using a previously described proto-
col [34]. Briefly, the cornea, lens and vitreous were
removed. Eye cup was rinsed with Ca2+ and Mg2+ Dul-
becco’s PBS allowing prompt separation of the neural
retina from the RPE and detachment of the choroid
from the sclera. The RPE cells adhering to Bruch’s mem-
brane on the choroidal sheets were washed with Hank’s
balanced salt solution (HBSS; GE Healthcare Life Sci-
ences, Waltham, MA, USA) and treated with 0.05 %
trypsin and 0.02 % EDTA. The cells were suspended in
complete Dulbecco’s modified Eagle’s medium F-12 nu-
trient mixture (DMEM/F-12; Invitrogen, Carlsbad, CA)
containing 10 % fetal bovine serum, 100 U/mL penicillin
(Beyotime, Shanghai, China) and 100 μg/mL strepto-
mycin (Beyotime), then transferred to 25-cm2 flasks. The
cells were incubated in a humidified incubator at 37 °C
in 5 % CO2. The homogeneity of cultured RPE cells was
confirmed by positive immunostaining with RPE65, a
specific marker of RPE cells. The cells used were from
passage 3~4.
Human RPE cell line ARPE-19 was purchased from the
American Type Culture Collection (ATCC; Manassas,
CA). Cells were cultured in DMEM/F12 (Dulbecco’s
modified Eagle’s medium: nutrient mixture F12, 1:1, Invi-
trogen, Carlsbad, CA) medium containing 10 % fetal bo-
vine serum (FBS; Invitrogen), 100 U/ml penicillin, and
100 μg/mL streptomycin. The cells were cultured at 37 °C
in humidified 5 % CO2 condition and detached with
0.25 % trypsin-EDTA (Invitrogen) solution, diluted 1:3 to
1:4, and plated for subculture. The ARPE-19 cells used in
the experiments were between passage 20 and 25.
Immunofluorescence staining
Isolated hPRE and ARPE-19 cells were seeded onto a
glass coverslips and incubated at 37 °C and 5 % CO2
until 80 % confluent. Cells were fixed with 4 % parafor-
maldehyde for 15 min at room temperature, followed by
three times wash with PBS. Fixed cells were incubated
with 0.1 % triton X-100 for 4 min and then blocked in
PBS containing 10 % goat serum for 30 min. Cells
were incubated with anti-RPE65 antibody (Abcam,
Cambridge, MA, USA) with the concentration of
1:100 overnight at 4 °C. Cells were washed three times
in PBS and incubated with goat anti-mouse IgG sec-
ondary antibody (DyLight 594; Abbkine, CA, USA) for
30 min at room temperature, followed by 2 min of
nuclear staining with DAPI. All fluorescent images
were taken with a fluorescence microscope (Model
DM6000; Leica, Wetzlar, Germany).
Cell viability assay
The effect of DIZE (Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA) on the viability of ARPE-19 cells were
determined using the cell counting kit-8 (CCK-8, Sigma-
Aldrich, St. Louis, MO) according to the manufacturer’s
instructions. ARPE-19 cells were plated in 96-well plates
at a density of 1 * 104 cells per well. After 2 days’ incuba-
tion, the medium was withdrawn. The cells were washed
with PBS and starved with serum-free medium for 24 h
and followed by pre-incubation with different concentra-
tions (0.01, 0.1, 1, 10, 100 μg/mL) of DIZE for 3, 6, and
12 h, then stimulated with 5 μg/mL LPS (Sigma-Aldrich)
for 24 h. Afterwards, 10 μl WST-8 was added to each
well, and incubated for 4 h. The optical density was read
at 450 nm using a multifunction microplate reader
(Molecular Devices, Sunnyvale, CA). Cells cultured with-
out DIZE were used as a control.
Experiment protocols
The hRPE and ARPE-19 cells were plated into 24-well
plates at a density of 2 * 105 cells per well and cultured
in DMEM/F12 medium containing 10 % FBS for 2 days
to become confluent. Before treatment, cells were
starved for 24 h in serum-free medium. RPE cells were
pre-incubated in serum-free medium with or without
10 μg/mL of DIZE for 6 h. Then, 5 μg/mL LPS was
added to the medium. Cells were cultured for 24 h, and
the supernatants were collected for ELISA assay. The
cells were subsequently harvested for mRNA and protein
assays. The DIZE-only group was treated the same way
as in DIZE + LPS group, except for adding LPS. The
assay samples were collected at the same time as in the
DIZE + LPS group.
To confirm the involvement of ACE2/Ang-(1-7)/
Mas axis, hRPE and ARPE-19 cells were seeded into
24-well plates to become confluent. Then serum-free
starved for 24 h and pre-incubated for 30 min with
10 μM of the Ang-(1-7) antagonist, A779 (Santa Cruz
Biotechnology), followed by incubation with 10 μg/mL
of DIZE. After 6 h, 5 μg/mL LPS was added to the
cells and cultured for 24 h. The supernatants were
collected and stored at −20 °C.
To investigate the involvement of MAPK and NF-κB
pathways in LPS-induced cytokine expression, ARPE-19
cells were seeded into 24-well plates to become conflu-
ent. After being serum-free starved for 24 h, cells were
pre-incubated for 30 min in serum-free medium with
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p38 inhibitor SB203580, extracellular signal-regulated
kinase 1/2 (ERK1/2) inhibitor PD98059, and JNK in-
hibitor SP600125 (all from Cell Signaling Technology,
Beverly, MA) and NF-κB inhibitor BAY 11-7082
(Sigma-Aldrich) at the concentration of 10 μM. Subse-
quently, 5 μg/mL LPS was added to the medium. After
24 h of incubation, the supernatants were collected
and stored at −20 °C.
ACE2 small-interfering RNA (siRNA) transfection and LPS
treatment
A siRNA-targeting specific sequence of ACE2 and a
negative control scrambled siRNA, which was not hom-
ologous to any gene, were synthesized by GenePharma
(Shanghai, China). The transfection was performed as
previously described [35]. The sequences of these siR-
NAs were shown in Table 1. The ARPE-19 cells and pri-
mary human RPE were seeded in 12-well plates (1–2 ×
105 cells/well) and cultured in 1 mL DMEM culture
medium containing 10 % FBS without antibiotics until
the cells were 50~60 % confluent. Before transfection,
cells were serum-free starved for 12 h. Lipofectamine®
2000 Transfection Reagent (Invitrogen, Carlsbad, CA)
was used to perform the transfection. The siRNA com-
plex was pre-mixed according to the manufacturer’s
instructions and added to the 12-well plates. The final
concentration of ACE2 and scrambled siRNA was
100 nM per well as the previous study [36]. Six hours
after transfection, the medium was changed to fresh
serum-free culture medium without antibiotics. The
cells were incubated with DIZE (10 μg/mL) for 6 h, and
then stimulated with LPS (5 μg/mL) for 24 h. The cell
samples were collected for subsequent assays.
Total RNA extraction and real-time PCR
Total RNA was extracted from hRPE and ARPE-19
cells by using Trizol Reagent (Invitrogen) according to
the manufacturer’s instructions. Complementary DNA
(cDNA) was generated using PrimeScript RT reagent
Kit (Takara Biotechnology, Dalian, China). Real-time
PCR (SYBR Green) was performed according to manu-
facturer’s instruction with a sequence detection system
(ABI Prism 7500; Applied Biosystems, Foster City, CA).
The real-time PCR amplification was performed in a
volume of 20 μL using all-in-one quantitative PCR mix
(Takara Biotechnology). The cycling protocol consisted
of 1 cycle of 10 min at 95 °C followed by 40 cycles of
95 °C for 15 s and 60 °C for 1 min. The mRNA expres-
sion was normalized to the endogenous reference gene
β-actin. Relative quantification was achieved by the
comparative 2−ΔΔct method as described [14]. The se-
quences of the primers are shown in Table 2.
Enzyme-linked immunosorbent assay
The concentrations of inflammatory cytokines IL-6, IL-
8, and MCP-1 (R&D Systems, Minneapolis, Minnesota,
CA), Ang II (Abcam, Cambridge, MA) and Ang-(1-7)
(Cloud-Clone, Houston, MA) were determined using the
ELISA kits for human according to the manufacturer’s
instructions. The absorbance at 450 nm wavelength was
measured using a multifunction microplate reader
(Molecular Devices).
Western blot analysis
Cells were washed with cold PBS for three times and
scraped off with RIPA lysis buffer (Beyotime) containing
50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 % Triton X-
100, 1 % sodium deoxycholate, 0.1 % SDS, 2 mM EDTA,
and 100 M phenylmethylsulfonyl fluoride. The cellular
lysate was centrifuged and supernatant was collected.
Protein concentration was detected by bicinchoninic
acid assay kit (Beyotime). Samples were denatured with
Laemmli loading buffer at 100 °C for 5 min. Eighty
microgram samples were loaded to an 8 to 12 % SDS-
polyacrylamide gel. Pre-stained markers (Beyotime) were
used to estimate molecular weight. Then proteins were
transferred to polyvinylidene difluoride membranes
(Millipore, Bedford, MA), blocked by 5 % non-fat skim
milk or 5 % bovine serum albumin-Tris-buffered saline
supplemented with Tween 20, the membranes were
incubated with primary antibodies against ACE2 (1:500,
Abcam, Cambridge, MA), p-p38, p38, ERK1/2 (1:1000;
Cell Signaling), p-JNK, JNK (1:500; Cell Signaling), p-
ERK1/2 (1:2000; Cell Signaling), p-IκB-α (1:50, Santa
Table 1 Sequences of small-interfering RNA
Gene Forward Reverse
ACE2-siRNA 5′-CCA UCU ACA GUA
CUG GAA A dTdT-3′
5′-UUU CCA GUA CUG
UAG AUG G dTdT-3′
Scrambled siRNA 5′-UUC UCC GAA CGU
GUC ACG U dtdt-3′
5′-ACG UGA CAC GUU
CGG AGA A dtdt-3′
Table 2 Sequences of the primers for real-time PCR
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Fig. 1 The optimum concentration and incubation time of DIZE in cultured ARPE-19 cell line. a The cell viability was measured by CCK-8 assay.
ARPE-19 cells were treated with 0.01, 0.1, 1, 10, and 100 μg/mL of DIZE for 3, 6, and 12 h and then stimulated with LPS for 24 h. (***p < 0.001,
###p < 0.001, +++p < 0.001, n = 6, “asterisk” “number sign” “plus sign” indicated pre-incubated with 100 μg/mL of DIZE for 3, 6, and 12 h versus time-
matched untreated cells, respectively). b ARPE-19 cells were pre-treated with 10 μg/mL of DIZE for 3, 6, and 12 h, following stimulated with LPS
for 24 h. The mRNA expression of IL-6, IL-8, and MCP-1 in the DIZE-treated groups were compared with the LPS group by real-time PCR. All data
are expressed as mean ± SEM. (***p < 0.001, **p < 0.01, *p < 0.05, n = 4 ~ 6)
Fig. 2 Identification of cutured hRPE and ARPE-19 cells. The RPE65 is a RPE-specific protein. It was used to identify whether the primary cells isolated
from the donor eyes, and the cell line were both derived from RPE. Merged images showed that the RPE65 was localized in the cytoplasm of the cells
with DAPI-positive nucleus in both the primary cultured hRPE and the ARPE-19. The RPE65-positive cells were counted in five non-overlapping fields
for each type of cell under a fluorescence microscope. The ratio of RPE65-positive cell was calculated as the percentage of RPE65-positive cells in the
DAPI-positive cells. The ratio was 96.1 % ± 1.4 % in ARPE-19 cells, and 91.3 % ± 4.7 % in the hRPE cells. The scale bar 100 μm, magnification ×200
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Cruz) and β-actin (1:100; Abcam) overnight at 4 °C.
Membranes were washed and incubated with horseradish
peroxidase-conjugated secondary antibody (1:2000 or
1:3000; Abcam) at 37 °C for 1 h. Bands were visualized by
ECL kit (Advansta, Menlo Park, CA), and band densitom-
etry was performed using ImageJ software (Bethesda, MD).
Fig. 3 Expression of ACE2 in DIZE pre-treated hRPE and ARPE-19 cells followed by LPS stimulation. The mRNA and protein expressions of ACE2 detected
by real-time PCR and Western blotting showed that the ACE2 levels increased in the DIZE group and the DIZE+LPS group when compared with the
untreated group and the LPS-treated group in both ARPE-19 cells (a) and hRPE (b). There was no significant difference between the untreated group
and the LPS group. The band intensity of ACE2 was normalized to β-actin. The mRNA level of ACE2 was detected by real-time PCR in both ARPE-19 cells
(c) and hRPE (d), which were transfected with ACE2-siRNA or the negative control scrambled siRNA. All data are expressed as mean ± SEM. (***p< 0.001,
**p< 0.01, *p< 0.05, n= 4)
Tao et al. Journal of Neuroinflammation  (2016) 13:35 Page 6 of 21
Fig. 4 (See legend on next page.)
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The band intensity of p-IκB-α was normalized to β-actin,
and the band intensity of p-p38, p-JNK, and p-ERK1/2 was
normalized to p38, JNK, and ERK1/2, respectively.
Statistical analysis
Results were expressed as mean ± SEM. Experimental
data of multiple groups were analyzed by one-way
ANOVA followed by Bonferroni correction. p < 0.05
was considered to be significantly different for all
experiments.
Results
Determine the optimum concentration and incubation
time of DIZE in ARPE-19 cells
The effect of DIZE on the viability of ARPE-19 cells
was tested with different concentrations of DIZE. Pre-
incubation of DIZE with the concentrations of 0.01,
0.1, 1, and 10 μg/mL for 3, 6, and 12 h followed by
stimulation with LPS for 24 h had no noticeable influ-
ence on the viability of ARPE-19 cells compared to the
untreated controls. However, pre-incubation with
100 μg/mL of DIZE for 3, 6, and 12 h followed by
stimulation with LPS for 24 h significantly decreased
the cell viability (Fig. 1 a). Therefore, a concentration
of 10 μg/mL of DIZE was used in subsequently experi-
ments. ARPE-19 cells were pre-treated with 10 μg/mL
DIZE for 3, 6, 12 h, then stimulated with 5 μg/mL of
LPS for 24 h. Real-time PCR was performed to meas-
ure the levels of inflammatory cytokines. The mRNA
levels of IL-6, IL-8, and MCP-1 were significantly
decreased in the cells pre-incubated with DIZE for 3,
6, and 12 h at concentration 10 μg/mL. Based on the
changes of cytokines’ mRNA, we chose 6 h as the pre-
incubation time for DIZE in following experiment
(Fig. 1b ,***p < 0.001, **p < 0.01, *p < 0.05, n = 4 ~ 6).
Identification of human retinal pigment epithelium (hRPE)
and ARPE-19 cell line
The antibody of the RPE-specific protein RPE65 was
used to identify the hRPE and the ARPE-19 cells. In the
primary human PRE cells, RPE65 was localized in the
cytoplasm around the DAPI-positive nucleus (Fig. 2).
The ARPE-19 cells presented same pattern. It indicated
that both the primary and the ARPE-19 cells were RPE-
derived cells. The RPE65-positive cells were counted in
five non-overlapping fields for each type of cell under a
fluorescence microscope. The percentage of the RPE65-
positive cell in DAPI-positive cells was calculated. The
percentage was 96.1 % ± 1.4 % in ARPE-19 cells, and
91.3 % ± 4.7 % in hRPE cells.
DIZE increased, whereas ACE2-siRNA decreased ACE2
expression in hRPE and ARPE-19 cells
To investigate the effect of DIZE on the expression of
ACE2 in hRPE and ARPE-19 cells, real-time PCR and
Western blotting were performed. The mRNA expres-
sion of ACE2 significantly increased in the DIZE+LPS
and DIZE group compared with the untreated group.
There was no statistical difference between the un-
treated group and the LPS group in both ARPE-19
cells (Fig. 3a) and hRPE cells (Fig. 3b). The protein
level of ACE2 was consistent with the mRNA expres-
sion. The protein expression of ACE2 increased re-
markably in the DIZE group and in the DIZE+LPS
group. There was no significantly difference between
the LPS group and the untreated group in both ARPE-
19 cells (Fig. 3a) and hRPE cells (Fig. 3b). In ARPE-19
cells (Fig. 3c) and in hRPE cells (Fig. 3d), the mRNA
expression of ACE2 was remarkably decreased by
ACE2-siRNA when compared with the DIZE+LPS
group and the DIZE+LPS group treated with the nega-
tive control scrambled siRNA. (***p < 0.001, **p < 0.01,
*p < 0.05, n = 4).
DIZE downregulated the overproduction of pro-
inflammatory cytokines in LPS-stimulated hRPE and ARPE-
19 cells
To investigate the effect of DIZE on the overproduction
of pro-inflammatory cytokines in hRPE and ARPE-19
cells stimulated with LPS, cells were pre-treated with or
without 10 μg/mL of DIZE for 6 h and then stimulated
with LPS for 24 h. The mRNA and protein expression of
the inflammatory cytokines was determined by real-time
PCR and ELISA assay. The levels of IL-6, IL-8, and
MCP-1 in the cells exposed to LPS were significantly
higher than the control group. Overexpression of IL-6,
IL-8, and MCP-1 induced by LPS was significantly inhib-
ited by DIZE. DIZE resulted in a reduction of mRNA
expression of IL-6, IL-8, and MCP-1 by 1.66-, 7.6-, and
1.71-fold in the DIZE+LPS group compared with the
LPS group in the ARPE-19 cells (Fig. 4a) and a reduction
by 1.35-, 3.28-, and 1.6-fold in the hRPE (Fig. 4b). In the
(See figure on previous page.)
Fig. 4 The mRNA and protein expressions of pro-inflammatory cytokines in DIZE pre-treated hRPE and ARPE-19 cells followed by LPS stimulation. Real-
time PCR and ELISA were conducted to determine the production of IL-6, IL-8, and MCP-1 in ARPE-19 cells (a) as well as hRPE (b). Exposure to LPS for
24 h caused a significant overproduction of IL-6, IL-8, and MCP-1 in the ARPE-19 cells and hRPE. Whereas overproduction of the cytokines was markedly
inhibited by DIZE. IL-6 and IL-8 protein levels were undetectable in the DIZE group. All data are expressed as mean ± SEM. (***p< 0.001, **p< 0.01,
*p< 0.05, n= 4)
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Fig. 5 Effect of ACE2-siRNA on the production of inflammatory cytokines in ARPE-19 cells and hRPE. IL-6, IL-8, and MCP-1 were detected by real-
time PCR and ELISA assay in both ARPE-19 cells (a) and hRPE (b). DIZE reduced the expression of IL-6, IL-8, and MCP-1 in LPS-treated cells at both
mRNA and protein levels, while ACE2-siRNA reversed this effect. All data are expressed as mean ± SEM (***p < 0.001, **p < 0.01, *p < 0.05, n = 4)
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Fig. 6 Effect of A779 on the production of inflammatory cytokines in ARPE-19 cells and hRPE. IL-6, IL-8, and MCP-1 were detected by real-time
PCR and ELISA assay in both ARPE-19 cells (a) and hRPE (b). In LPS-treated cells, DIZE reduced the expression of IL-6, IL-8, and MCP-1, while A779
reversed this effect. All data are expressed as mean ± SEM (***p < 0.001, **p < 0.01, *p < 0.05, n = 4)
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Fig. 7 (See legend on next page.)
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DIZE+LPS group, the protein levels of IL-6, IL-8, and
MCP-1 significantly decreased (2.55-, 3.38-, 1.79-fold)
than the LPS group in the ARPE-19 cells (Fig. 4a) and
1.6-, 5.31-, and 1.54-fold decreased in the hRPE (Fig. 4b).
There was no difference of IL-6, IL-8, and MCP-1 ex-
pression between the untreated group and the DIZE
group at both mRNA and protein levels. (***p < 0.001,
**p < 0.01, *p < 0.05, n = 4).
A small interfering RNA of ACE2 and an Ang-(1-7)
antagonist A779 abrogated the anti-inflammatory effect
of DIZE
To investigate whether DIZE exerted the protective role
by activating ACE2 and the involvement of the ACE2/
Ang-(1-7)/Mas axis, we transfected the ARPE-19 cells
and hRPE with ACE2-siRNA or treated them with
A779. Both ACE2-siRNA and A779 offset the anti-
inflammatory effect of DIZE. They reversed the reduc-
tion of IL-6, IL-8, and MCP-1 at both mRNA and
protein levels in the ARPE-19 cells (Figs. 5 and 6a)
and the hRPE (Figs. 5, 6b) (***p < 0.001, **p < 0.01, *p
< 0.05, n = 4).
DIZE decreased the expression of Ang II, AT1R but
increased Ang-(1-7), while ACE2-siRNA and A779 reversed
these effects
Ang II is the main effector of RAS. Increase of Ang II
could exert a series of detrimental effects mediated by
its receptor AT1R. However, ACE2 could cleave Ang II
to generate Ang-(1-7), which is a member of the protect-
ive axis of RAS: ACE2/Ang-(1-7)/Mas. To investigate
whether the protective role of DIZE is mediated by
activating ACE2 and by switching Ang II to Ang-(1-7),
we detected the expression of Ang II and Ang-(1-7) by
ELISA. DIZE significantly reduced the Ang II level com-
pared with the LPS-treated ARPE-19 cells and hRPE.
While ACE2-siRNA and A779 reversed the inhibition
effect of DIZE (Fig. 7a). On the contrary, DIZE resulted
in dramatically increase of Ang-(1-7) compared with the
LPS treated ARPE-19 cells and hRPE. Whereas ACE2-
siRNA and A779 reversed the effect of DIZE (Fig. 7b).
The protein fold changes of Ang II and Ang-(1-7) were
shown in Table 3. Moreover, studies have shown that
AT1R increases in response to the inflammation stimuli.
AT2R might display a counteraction role of AT1R. Thus,
we investigated the effect of ACE2 on the expression of
AT1R and AT2R. LPS treatment significantly increased
the expression of AT1R, while DIZE reduced it. ACE2-
siRNA abolished the inhibition effect of DIZE. It in-
creased AT1R compared with DIZE+LPS group in both
ARPE-19 cells (Fig. 8a) and hRPE (Fig. 8b). However,
A779 did not abrogate the effect of DIZE on the expres-
sion of AT1R. Furthermore, there was no significance of
AT2R expression in each group (Fig. 8a, b).
Inhibitors of the MAPK and NF-κB pathways reduced the
overproduction of inflammatory cytokines in ARPE-19
cells stimulated with LPS
To investigate whether the signaling pathways were
involved in LPS-induced cytokine overproduction in
ARPE-19 cells, the selective inhibitors of p38 (SB203580,
SB), ERK1/2 (PD98059, PD), JNK (SP600125, SP), and
NF-κB (BAY 11-7082, BAY) were applied 30 min before
LPS administration. SB, PD, SP, and BAY significantly
inhibited the mRNA and protein overproduction of IL-6,
IL-8, and MCP-1. Compared with the LPS group, the
mRNA expression of IL-6, IL-8, and MCP-1 in the LPS
+SB group decreased remarkably by 4.41-, 3.66-, and
(See figure on previous page.)
Fig. 7 Effect of DIZE, A779, and ACE2-siRNA on the expression of Ang II and Ang-(1-7) in ARPE-19 cells and hRPE. The protein expression of Ang II
and Ang-(1-7) was detected by ELISA assay in both ARPE-19 cells and hRPE. DIZE reduced the expression of Ang II in response to LPS, while A779
and ACE2-siRNA reversed this effect (a). DIZE increased the expression of Ang-(1-7) compared with LPS-treated cells, while A779 and ACE2-siRNA
reversed this effect (b). All data are expressed as mean ± SEM (***p < 0.001, **p < 0.01, *p < 0.05, n = 4 ~ 6)
Table 3 The protein fold changes (vs. the LPS group)
Protein Cell line Group Change Fold change
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5.74-fold, respectively (Fig. 9a). The protein level of IL-6,
IL-8, and MCP-1 in the LPS+SB group reduced by 3.56-,
4.39-, and 1.42-fold when compared with the LPS group
(Fig. 9a). The mRNA expression of IL-6, IL-8, and
MCP-1 in the LPS+SP group decreased by 1.63-, 4.80-,
and 11.69-fold, respectively, when compared with the
LPS group (Fig. 9a). The protein level of IL-6, IL-8, and
MCP-1 in the LPS+SP group was reduced by 2.67-,
7.83-, and 2.00-fold compared with the LPS group
(Fig. 9a). PD treatment led to significant decrease of the
inflammatory cytokines’ mRNA. The mRNA expression
of IL-6, IL-8, and MCP-1 decreased by 3.43-, 3.26-, and
2.66-fold, respectively (Fig. 9a), and there was 4.36-,
2.90-, and 1.47-fold reduction of IL-6, IL-8, and MCP-1
protein in the LPS+PD group compared with the LPS
group (Fig. 9a). The mRNA expression of IL-6, IL-8,
and MCP-1 in the LPS+BAY group decreased by 1.95-,
1.85-, and 2.39-fold, respectively, compared with the
LPS group (Fig. 9b). The protein level of IL-6, IL-8, and
MCP-1 in the LPS+BAY group was reduced by 2.60-,
2.01-, and 1.73-fold compared with the LPS group
(Fig. 9b) (***p < 0.001, **p < 0.01, *p < 0.05, n = 4 ~ 6).
The mRNA and protein fold changes of pro-inflammatory
cytokines were shown in Table 4.
DIZE downregulated the phosphorylation of MAPKs and
NF-κB in ARPE-19 cells stimulated with LPS
MAPKs and NF-κB signaling pathways are critical in
regulating the production of pro-inflammatory cytokines
in various cells [37–39]. To further explore the
underlying mechanisms by which DIZE suppressed LPS-
induced pro-inflammatory cytokine production, we
tested the protein expression of phosphorylated tran-
scription inhibition factor-κB-α (p-IκB-α), an indicator
of the activation of NF-κB, phosphorylated p38 (p-p38),
p-JNK, and p-ERK1/2. Western blotting results showed
that the expression of p-p38, p-JNK, p-ERK1/2, and p-
IκB-α were significantly higher in the LPS-stimulated
group compared with the DIZE group and the un-
treated group. DIZE treatment (DIZE+LPS group) re-
sulted in remarkably reduction in protein expression of
p-p38, p-JNK, p-ERK1/2, and p-IκB-α compared with
the LPS-stimulated group (Fig. 10a, b). DIZE exerted
anti-inflammatory effect by inhibiting the activation of
MAPK and NF-κB pathways in cells stimulated with
LPS. (***p < 0.001, **p < 0.01, *p < 0.05, n = 3 ~ 4). A779
abrogated the protective role of DIZE via offsetting the
inhibition of the MAPK and the NF-κB pathways at
protein level (Fig. 11). ACE2-siRNA also abolished
the beneficial effect of DIZE by inhibiting the MAPK
and the NF-κB pathways at the protein level (Fig. 12)
(***p < 0.001, **p < 0.01, *p < 0.05, n = 3 ~ 4).
Discussion
We investigated the effect of DIZE on LPS-induced
inflammatory response in hRPE and ARPE-19 cells. We
showed that DIZE reduced the overexpression of IL-6,
IL-8, and MCP-1 in response to LPS stimulation, and
the effect is associated with the activation of the ACE2/
Ang-(1-7)/Mas axis. DIZE treatment also decreased the
expression of Ang II, AT1R but increased Ang-(1-7).
Meanwhile, we found that the MAPK and NF-κB path-
ways were involved in the LPS-induced overproduction
of IL-6, IL-8, and MCP-1. Whereas, pre-treatment with
DIZE downregulated phosphorylation of p38MAPK,
JNK, ERK1/2 and inhibited NF-κB pathway. On the
other hand, the ACE2-siRNA and an Ang-(1-7) antagon-
ist reversed the protective effect of DIZE. Taking to-
gether, we suggest that the protective effects of DIZE on
LPS-induced inflammatory response were mediated by
activating the ACE2/Ang-(1-7)/Mas axis and by inhibit-
ing the MAPK and NF-κB pathways.
RAS is considered traditionally a blood-pressure-
regulating system. Whereas, increasing evidence sug-
gests that it is also important in regulating inflammatory
responses. Hyperactivation of the ocular intrinsic RAS
contributes to an upregulation of ACE/Ang II/AT1R axis
and a downregulation of ACE2/Ang-(1-7)/Mas axis. It
has been proposed to be critical in the development of
various vision-threatening diseases [4], such as diabetic
retinopathy, AMD, and uveitis. Ang II, the main effector
molecule of RAS, contributes to the inflammatory
process by increasing the release of pro-inflammatory
cytokines, chemokines, and cell adhesion molecules,
growth factors, and reactive oxygen species through the
AT1R [40]. There is a direct evidence that abnormal
production of Ang II in RPE would lead to retinal dys-
function and breakdown of blood-retinal barrier [41].
Ang II was capable of weakening the tight junction of
blood-retinal barrier and increasing invasion of the chor-
oidal endothelial cells [42]. On the other hand, AT1R
blockers and ACE inhibitors have been shown to de-
crease the expression of inflammatory cytokines and
suppress ocular inflammation [43] as well as vascular
inflammation [44]. Recent studies have shown that
ACE2 acts as a counter-regulator of ACE in modulating
(See figure on previous page.)
Fig. 8 Effect of DIZE, A779, and ACE2-siRNA on the expression of AT1R and AT2R in ARPE-19 cells and hRPE. The mRNA level of AT1R and AT2R was
detected by real-time PCR in both ARPE-19 cells and hRPE. DIZE reduced the expression of AT1R in response to LPS, while ACE2-siRNA reversed this
effect. A779 did not affect the expression of AT1R. There was no significant difference of AT2R expression among each group in ARPE-19 cells (a) and
hRPE (b). All data are expressed as mean ± SEM (***p < 0.001, **p < 0.01, *p < 0.05, n = 4)
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the production of Ang-(1-7) [8, 9]. The ACE2/Ang-(1-
7)/Mas axis negatively regulates leukocyte migration and
cytokine release and consequently inhibits inflammatory
responses [45]. Overexpression of ACE2 reversed the
imbalance of ACE2/ACE, reduced Ang II but increased
Ang-(1-7) levels, suppressed secretion of IL-1β and
tumor necrosis factor (TNF)-α in LPS-stimulated
PMVECs [11]. Moreover, ACE2 deletion and Mas recep-
tor inhibition exhibited parallel deleterious effects on
LPS-induced damage and cytokine secretion by offset-
ting the protective effect of ACE2 overexpression [11].
Thus, we proposed that activating ACE2 could exert
protection against LPS-induced ocular inflammation.
In line with the previous study, we showed that ACE2
overexpression mediated by DIZE resulted in significant
decrease of Ang II and AT1R, whereas Ang-(1-7) was
dramatically increased by DIZE. Furthermore, ACE2-
siRNA and A779 reversed these effects. Nevertheless,
A779 did not affect the expression of AT1R after DIZE
treatment in LPS group. A possible explanation is A779
is the antagonist of Ang-(1-7). It blocks the ACE2/Ang-
(1-7)/Mas axis, but cannot reduce the expression of
ACE2. ACE2 is capable to convert Ang II to Ang-(1-7),
thus decrease Ang II and ultimately reduce the expres-
sion of AT1R. However, the mRNA expression of AT2R
was not affected by any of the treatments. There might
be two possibilities. On the one hand, there are large
amount of AT2R expressed in the embryonic tissue, but
the expression is less in the adult tissues. Either the LPS
stimulation will not cause dramatically changes of AT2R
expression, or it may not be involved in the LPS-
induced response in RPE cells. On the other hand, there
is evidence showing when AT1R is blocked, circulating
Ang II binds, and activates AT2R only [46]. When the
cells are exposed to LPS, Ang II is increased and binds
to AT1R, thus the AT2R will not be bound or acti-
vated. It is in accordance with our results that the
mRNA expression of AT2R was comparable in cells
treated with LPS and in untreated cells. In cells
treated with DIZE followed by LPS, ACE2 was in-
creased and it could reduce the expression of Ang II,
so AT2R was not activated.
DIZE modulates the RAS in a positive manner. It
reduces inflammatory cytokines and improves the func-
tion of angiogenic progenitor cell in a pulmonary hyper-
tension model [16]. More recently, it was confirmed that
DIZE reduced infiltration of inflammatory cells and
attenuated ocular inflammatory responses in rodent
models of EIU [14, 17]. The protective effect of DIZE
was believed to be mediated by activating ACE2. Our
study confirmed that the expression of ACE2 increased
after DIZE treatment.
We found that DIZE not only significantly augmented
the expression of ACE2 in the hRPE and ARPE-19 cells,
but also decreased the production of IL-6, IL-8, and
MCP-1 when stimulated with LPS. We showed DIZE
exerted beneficial effect by activating the expression of
ACE2, subsequently alleviated inflammatory response
through generating Ang-(1-7) and/or degrading Ang II.
Furthermore, ACE2-siRNA and an Ang-(1-7) antagonist
A779 offset the protective effect of DIZE. This effect was
attributed to the suppression of ACE2/Ang-(1-7)/Mas
axis. Therefore, the protective effect of DIZE on LPS-
induced inflammation in hRPE and ARPE-19 cells was
regulated by activating the ACE2/Ang-(1-7)/Mas axis.
The RPE play an essential role in maintaining nor-
mal visual function, and it can be involved in many
ocular inflammatory conditions. In response to pro-
inflammatory stimuli, RPE are capable of producing a
variety of cytokines, which are crucial to ocular in-
flammation [47]. Our study demonstrated for the first
time that enhancing ACE2 exerts anti-inflammatory
role in RPE cells. However, there are also many other
types of cell are activated during ocular inflammation,
(See figure on previous page.)
Fig. 9 Effect of the MAPK and NF-κB inhibitors on the mRNA and protein expression of inflammatory cytokines in LPS-stimulated ARPE-19 cells. The
expression of IL-6, IL-8, and MCP-1 was detected by real-time PCR and ELISA assay in the MAPK pathway inhibitor-treated cells (a) and NF-κB pathway
inhibitor-treated cells (b). The p38 inhibitor (SB203580, SB), JNK inhibitor (SP600125, SP), and ERK1/2 inhibitor (PD98059, PD) significantly decreased the
production of IL-6, IL-8, and MCP-1 in the ARPE-19 cells stimulated with LPS at both mRNA and protein levels (a). The NF-κB inhibitor (BAY 11-7082,
BAY) remarkably reduced the production of IL-6, IL-8, and MCP-1 in LPS-treated group at both mRNA and protein levels (b). All data are expressed as
mean ± SEM (***p < 0.001, **p < 0.01, *p < 0.05, n = 4)
Table 4 The mRNA and protein fold changes of pro-inflammatory
cytokines (vs. the LPS group)
Group Cytokines mRNA fold change Protein fold change
LPS+SB IL-6 4.41 3.56
IL-8 3.66 4.39
MCP-1 5.74 1.42
LPS+SP IL-6 1.63 2.67
IL-8 4.80 7.83
MCP-1 11.69 2.00
LPS+PD IL-6 3.43 4.36
IL-8 3.26 2.90
MCP-1 2.66 1.47
LPS+BAY IL-6 1.95 2.60
IL-8 1.85 2.01
MCP-1 2.39 1.73
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such as microglia and Müller cells. Our previous
study provided direct evidence that activating ACE2
by DIZE significantly decreased the number of CD45+
macrophages in endotoxin-induced uveitis mice [14].
AAV-mediated intravitreal delivery of ACE2 conferred
protection against diabetic retinopathy by reducing
the retinal CD11b+ microglia cell [12]. These data
indicated that enhancing ACE2 may be a potential
therapeutic target for various ocular inflammatory
diseases which not only affect RPE, but also affect
other retinal immune cells.
Moreover, in response to inflammatory stimuli, inflam-
matory response is orchestrated by initiating a series of
intracellular signaling cascades and ultimately leads to
release of pro-inflammatory cytokines. Prominent cas-
cades among these intracellular signaling pathways in-
clude MAPK and NF-κB pathways. LPS initiated the
production of pro-inflammatory cytokines by activating
Fig. 10 Effect of DIZE on the phosphorylation levels of MAPKs and the activation of NF-κB in ARPE-19 cells stimulated with LPS. a Western blotting
was used to determine the protein levels of p38 MAPK, JNK, ERK1/2 and their phosphorylated forms (p-p38, p-JNK, and p-ERK1/2). b Activation of
NF-κB pathway was indicated by p-IκB-α, an indicator for the activation of NF-κB. The expressions of p-p38, p-JNK, and p-ERK1/2 were normalized
to p38, JNK, and ERK1/2, respectively. The band intensity of p-IκB-α was normalized to β-actin. DIZE treatment resulted in remarkably reduction of
phosphorylation of p38, JNK, ERK1/2, and IκB-α compared with the LPS-stimulated group. All data are expressed as mean ± SEM (***p < 0.001,
**p < 0.01, *p < 0.05, n = 3 ~ 4)
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the MAPK and NF-κB cascades [48]. In addition, treat-
ment with recombinant ACE2 ameliorated LPS-induced
cellular apoptosis and inflammation. A possible under-
lying mechanism that ACE2 exerts its anti-inflammatory
effect is by blocking the activation of p38MAPK and
JNK [11]. It has been shown that DIZE dramatically
suppressed the production of pro-inflammatory cyto-
kines after LPS treatment by downregulating the phos-
phorylation of MAPKs (p38MAPK, JNK, ERK), STATs,
and NF-κB, which were the key signaling molecules and
transcription factors involved in the production of pro-
inflammatory cytokines in immune cells [33].
Although activation of the MAPK pathway plays a
key role in inflammatory response, its role in RPE
cells underwent LPS stimulation has not been fully
elucidated. In consistent with the previous studies in
other cellular systems [39], we found that the phos-
phorylation levels of p38MAPK, ERK1/2, and JNK
were enhanced in ARPE-19 cells stimulated with LPS.
Furthermore, specific inhibitors of p38MAPK, ERK1/
Fig. 11 Effect of A779 on the phosphorylation of MAPKs and the activation of NF-κB in ARPE-19. Western blotting was applied to determine the
protein levels of p-p38, p-JNK, p-ERK1/2, p38, JNK, ERK1/2 (a) and p-IκB-α, an indicator for the activation of NF-κB (b). The band intensity of p-p38,
p-JNK, and p-ERK1/2 was normalized to p38, JNK, and ERK1/2, respectively. The band intensity of p-IκB-α was normalized to β-actin. DIZE reduced
the phosphorylation of p38, JNK, and ERK1/2 and IκB-α induced by LPS, while A779 abrogated DIZE’s effect. All data are expressed as mean ± SEM
(***p < 0.001, **p < 0.01, *p < 0.05, n = 3 ~ 4)
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2, and JNK decreased the production of inflammatory
cytokines. Therefore, all of the three MAPK family mem-
bers were involved in the LPS-induced inflammatory
response in RPE cells. We also showed that DIZE remark-
ably decreased the phosphorylation of p38MAPK, JNK,
and ERK1/2 in response to LPS, whereas ACE2-siRNA
and A779 abolished the protective effect of DIZE. Thus,
we suggested that DIZE protected against LPS-induced
inflammation through the ACE2/Ang-(1-7)/Mas axis by
modulating the phosphorylation of p38MAPK, JNK,
and ERK1/2.
The NF-κB pathway is pivotal to the inflammatory
response. NF-κB normally resides in the cytoplasm as
an inactive form complex with an inhibitor namely
Fig. 12 Effect of ACE2-siRNA on the phosphorylation of MAPKs and the activation of NF-κB in ARPE-19. The protein levels of p-p38, p-JNK, p-ERK1/2,
p38, JNK, ERK1/2 (a) and p-IκB-α (b) were determined by Western blotting. The band intensity of p-p38, p-JNK, and p-ERK1/2 was normalized to p38,
JNK, and ERK1/2, respectively. The band intensity of p-IκB-α was normalized to β-actin. DIZE reduced the phosphorylation of p38, JNK, and ERK1/2 and
IκB-α induced by LPS, while ACE2-siRNA abolished DIZE’s effect. All data are expressed as mean ± SEM (***p < 0.001, **p < 0.01, *p < 0.05, n = 3 ~ 4)
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transcription inhibition factor-κB (IκB). External stim-
uli activate NF-κB transcription, lead to the phos-
phorylation of IκB-α, and increase the degradation of
IκB by proteosome [49]. NF-κB is activated and trans-
located into the nucleus to upregulate the transcrip-
tion of several inflammatory genes. Many in vitro and
in vivo studies demonstrated that activation of NF-κB
is the key link in regulating the LPS-induced inflam-
matory response [39, 50]. Inhibiting NF-κB signaling
reduced the pro-inflammatory cytokines production in
LPS-induced uveitis and in RPE cells [51]. Here, we
confirmed that LPS increased the activation of NF-κB
in RPE cells, and the specific inhibitor of NF-κB
significantly decreased the pro-inflammatory cytokines
generation. Our results proved that the NF-κB signaling
was involved in LPS-induced inflammatory response in
ARPE-19 cells. More interestingly, we found that DIZE
remarkably suppressed the activation of NF-κB induced
by LPS. In addition, ACE2-siRNA and pre-treatment of
A779 abrogated the inhibition effect of DIZE on NF-κB
pathway, suggesting that the beneficial effect of DIZE on
LPS-induced inflammation was through modulating the
ACE2/Ang-(1-7)/Mas axis by down-regulating the activa-
tion of NF-κB pathway.
Conclusions
In conclusion, we demonstrate that by activating the
protective axis of RAS, ACE2/Ang-(1-7)/Mas, DIZE
exerts protective effects on LPS-induced inflammatory
response in hRPE and ARPE-19 cells. Our results
strongly suggest that the anti-inflammatory effect of
DIZE is mediated by inhibiting the MAPK and NF-κB
pathways. Upregulation of the ACE2/Ang-(1-7)/Mas axis
is beneficial in the LPS-induced inflammation. It may
shed light on finding a novel promising therapeutic
strategy against ocular inflammation.
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